A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting · NCT07365995 · Registry updated 2026-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | Recruiting | Phase 3 | 2026-09-18 | NCT07365995 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioNTech (Shanghai) Pharmaceuticals Co., Ltd. | 9 |
| BioNTech SE | 53 |
| DualityBio Inc. | 15 |
33 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.